Muscle Oxygenation and Skin Pigmentation

Withdrawn before enrolling · Phase 4

Conditions studied: Muscle Oxygenation, Skin Pigmentation

In brief

The investigators plan to enroll 500 consecutive Subjects at a major trauma center for this study. For each patient, the body mass index (BMI), age, sex, diastolic pressure and mean arterial pressure (MAP) at time of measurements. Additional information including diseases such as diabetes and vascular disorders will be recorded. Social demographics including alcohol and tobacco use will be recorded. This is important as alcohol and tobacco use could also contribute to cardiovascular diseases. The skin pigmentation of each subject will be recorded. Two different methods will be used for this measurement. Each patient will be graded on a six point scale as described by Young (Young, 1997). Additionally, each subject will have their skin measured using a reflectance colorimeter. The colorimeter, DermaSpectrometer II (cyberDerm, Broomall, PA) uses visible light to measure the amount of light reflected off the skin. By measuring the light reflectance, the skin pigmentation can be measure (Clarys, 2000). Muscle oxygenation will be measured using a continuous dual wavelength near infrared spectrometer. Using the different absorption characteristics of deoxyhemoglobin and oxyhemoglobin, the concentration of oxyhemoglobin in the muscle at an approximate depth of 2.5 cm is determined. The INVOS cerebral oximeter (Somanetics, Troy, MI) will be used for all measurements.

Key facts

Study ID

NCT00747162

Run by

Emory University

People needed

0

Starts

2008-08-01

Expected to finish

2009-02-01

Last updated by the study team

2013-11-27

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Male or Female between the ages of 18 and 75 years old
• Subjects that have no lower extremity injuries.
• Subject who are classified as being either light or dark skin pigmentation.
• Subjects willing to participate in the study.

You may not qualify if…

• Patients with previous injury to either lower extremity
• Patients with previously diagnosed vascular disease or insufficiency
• Patients with pulmonary insufficiency or severe pulmonary injury
• Patients not willing to consent to participate

Where it is running

• Grady Healthcare System — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.